These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 23601343

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
    Dodd C, Watts RG.
    Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective.
    Pérez Bianco R, Ozelo MC, Villaça PR, Solano MH, Jimenez Cruze G, Martinez Murillo C, Garcia Chavez J, Mendoza S, Rodriguez Grecco I, Ruiz-Saez A.
    Medicina (B Aires); 2008 Jul; 68(3):227-42. PubMed ID: 18689157
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prophylaxis in children with haemophilia - the Polish experience.
    Klukowska A, Urasinski T, Janik-Moszant A, Bobrowska H, Balwierz W, Woznica-Karczmarz I, Dobaczewski G, Wlazlowski M, Koltan A, Badowska W, Dakowicz L, Karolczyk G, Kostrzewska M, Korczowski B, Wasinski D, Pietrys D, Laguna P, Wysocka M.
    Haemophilia; 2014 Jan; 20(1):e108-10. PubMed ID: 24251651
    [No Abstract] [Full Text] [Related]

  • 8. Treatment patterns and bleeding outcomes in persons with severe hemophilia A and B in a real-world setting.
    Ay C, Perschy L, Rejtö J, Kaider A, Pabinger I.
    Ann Hematol; 2020 Dec; 99(12):2763-2771. PubMed ID: 32918114
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries.
    Noone D, O'Mahony B, van Dijk JP, Prihodova L.
    Haemophilia; 2013 Jan; 19(1):44-50. PubMed ID: 22913831
    [Abstract] [Full Text] [Related]

  • 13. Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries.
    Ljung R, Aronis-Vournas S, Kurnik-Auberger K, van den Berg M, Chambost H, Claeyssens S, van Geet C, Glomstein A, Hann I, Hill F, Kobelt R, Kreuz W, Mancuso G, Muntean W, Petrini P, Rosado L, Scheibel E, Siimes M, Smith O, Tusell J.
    Haemophilia; 2000 Nov; 6(6):619-24. PubMed ID: 11122385
    [Abstract] [Full Text] [Related]

  • 14. A global view on prophylaxis: possibilities and consequences.
    Shapiro AD.
    Haemophilia; 2003 May; 9 Suppl 1():10-7; discussion 18. PubMed ID: 12709032
    [Abstract] [Full Text] [Related]

  • 15. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
    Thornburg CD, Pipe SW.
    Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of hemophilia].
    Straub PW.
    Dtsch Med Wochenschr; 1969 Sep 12; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract] [Full Text] [Related]

  • 17. Unresolved issues in prophylaxis.
    Brown SA, Aledort LM, Astermark J, Berntorp E, van den Berg M, Blanchette V, Donfield S, Gringeri A, Hilgartner M, Kulkarni R, Leissinger C, Negrier C, Nuss R, Petterson H, Petrini P, Poulios N, Schramm W, Round Table Group.
    Haemophilia; 2002 Nov 12; 8(6):817-21. PubMed ID: 12410654
    [No Abstract] [Full Text] [Related]

  • 18. Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy.
    Giampaolo A, Abbonizio F, Puopolo M, Arcieri R, Mannucci PM, Italian Association of Haemophilia Centres, Hassan HJ, Accorsi A, Ettorre PC, Schiavoni M, Palareti G, Rodorigo G, Valdré L, Amaddii G, Billio A, Notarangelo L, Iannacaro P, Muleo P, Biasioli C, Rossi V, Alatri A, Testa S, Vincenzi D, Scapoli G, Morfini M, Molinari AC, Lapecorella M, Mariani G, Baudo F, Caimi MT, Federici AB, Gringeri A, Mannucci PM, Santagostino E, Marietta M, Coppola A, Di Minno G, Perricone C, Schiavulli M, Miraglia E, Rocino A, Zanon E, Gagliano F, Mancuso G, Siragusa S, Rivolta F, Tagliaferri A, Gamba G, Iorio A, Oliovecchio E, Dragani A, Arbasi MC, Albertini P, Mancino A, Lombardo VT, Latella C, D'Incà M, Landolfi Raffaele, Biondo Francesca, Mazzucconi MG, Santoro Cristina, Mameli AL, Piseddu G, Schinco PC, Messina M, Rossetti G, Barillari G, Feola G, Franchini M, Gandini G, Castaman G, Rodeghiero F.
    Transfus Med; 2011 Aug 12; 21(4):280-4. PubMed ID: 21733006
    [No Abstract] [Full Text] [Related]

  • 19. Role of enhanced half-life factor VIII and IX in the treatment of haemophilia.
    Mahdi AJ, Obaji SG, Collins PW.
    Br J Haematol; 2015 Jun 12; 169(6):768-76. PubMed ID: 25754016
    [Abstract] [Full Text] [Related]

  • 20. Progress in the treatment of bleeding disorders.
    Bergman GE.
    Thromb Res; 2011 Jan 12; 127 Suppl 1():S3-5. PubMed ID: 21035836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.